McKesson (NYSE: MCK) — Perfil da empresa, notícias e dados financeiros
McKesson is a global healthcare company focused on pharmaceutical distribution and healthcare services.
McKesson
McKesson is a healthcare services and information technology company distributing pharmaceuticals, medical supplies, and health care products across North America. The company serves pharmacies, hospitals, clinics, and physicians' offices through a comprehensive logistical and distribution network. Beyond pharmaceutical and medical-surgical distribution, McKesson provides pharmacy management software, oncology and multispecialty support services, biopharma capabilities, and prescription benefit solutions. Headquartered in Irving, Texas, the company operates across the United States and Canada, playing a critical operational role in the healthcare supply chain by facilitating patient access to therapies and medical supplies.
Resumo
Operações
Produtos e/ou serviços de McKesson
- Pharmaceutical Distribution Services: Wholesaling and supply chain delivery of branded, generic, specialty, and over-the-counter pharmaceutical products to retail pharmacies, institutional healthcare providers, health systems, and government facilities across North America.
- Medical Supply Distribution: Sourcing and distributing medical-surgical supplies, equipment, personal protective gear, and care management products to physician offices, surgery centers, long-term care facilities, and home health care agencies throughout the United States.
- Pharmacy Services: Providing operational software, pharmacy management technology, group purchasing programs, revenue cycle tools, and clinical workflow solutions to independent pharmacies, retail chain locations, health system departments, and outpatient clinics.
- Oncology & Multispecialty Solutions: Operating practice management services, clinical research networks, specialized health technology platforms, electronic health records, and data analytics tools designed for community oncology practices, specialty clinics, and trial sponsors.
- Biopharma Capabilities: Delivering commercial strategy, clinical trial recruitment, patient access programs, copay assistance tools, hub services, and medication adherence technologies connecting biopharmaceutical manufacturers, health plans, retail pharmacies, and patients.
- Prescription Benefit Solutions: Developing healthcare technology platforms, prescription discount programs, relay network transaction services, and claim adjudication solutions that assist employers, health plan brokers, third-party administrators, and government agencies in managing pharmacy spend.
equipe executiva do McKesson
- Brian S. TylerCEO & Chairman
- Michele LauExecutive VP & Chief Legal Officer
- LeAnn B. SmithExecutive VP & Chief Human Resources Officer
- Kenny K. CheungExecutive VP & CFO
- Napoleon B. Rutledge Jr.Senior VP, Controller & Chief Accounting Officer
- Paula AdkisonSenior Vice President of Corporate Finance, Investor Relations & Strategic Finance
- Francisco J. FragaExecutive VP, Chief Information Officer & CTO
- Jeni DominguezHead of Investor Relations
- Kirk KaminskyExecutive VP & Group President of North American Pharmaceutical Services
- Stanton J. McCombPresident of Medical-Surgical
Últimas notícias sobre a McKesson
Histórico de dividendos
Dividendos por ação pagos pela McKesson , por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2027(até o momento) | — | — | — | $1.7600 |
| FY2026 | — | — | — | $3.1700 |
| FY2025 | — | — | — | $2.7500 |
| FY2024 | — | — | — | $2.4000 |
| FY2023 | — | — | — | $2.0900 |
Principais indicadores financeiros
Resultados divulgados pela McKesson , em USD.
- Cap. de mercado
- 112,7 bi
- Receita (TTM)
- 411 bi
- P/L
- 25.9
- LPA (diluído, TTM)
- 37.3
- Dividend yield
- 0.3%
- Margem de lucro
- 1.1%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 403,4 bi | 6,5 bi | 4,8 bi | |
| 359,1 bi | 4,4 bi | 3,3 bi | |
| 309 bi | 3,9 bi | 3 bi | |
| 276,7 bi | 4,5 bi | 3,6 bi |